1. Kaelin, W.G., Jr. (2005). The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5, 689-698. 10.1038/nrc1691.
2. Tsherniak, A., Vazquez, F., Montgomery, P.G., Weir, B.A., Kryukov, G., Cowley, G.S., Gill, S., Harrington, W.F., Pantel, S., Krill-Burger, J.M., et al. (2017). Defining a Cancer Dependency Map. Cell 170, 564-576 e516. 10.1016/j.cell.2017.06.010.
3. McDonald, E.R., 3rd, de Weck, A., Schlabach, M.R., Billy, E., Mavrakis, K.J., Hoffman, G.R., Belur, D., Castelletti, D., Frias, E., Gampa, K., et al. (2017). Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening. Cell 170, 577-592 e510. 10.1016/j.cell.2017.07.005.
4. Dharia, N.V., Kugener, G., Guenther, L.M., Malone, C.F., Durbin, A.D., Hong, A.L., Howard, T.P., Bandopadhayay, P., Wechsler, C.S., Fung, I., et al. (2021). A first-generation pediatric cancer dependency map. Nat Genet 53, 529-538. 10.1038/s41588-021-00819-w.
5. Sun, C.X., Daniel, P., Bradshaw, G., Shi, H., Loi, M., Chew, N., Parackal, S., Tsui, V., Liang, Y., Koptyra, M., et al. (2023). Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities. Cancer Cell 41, 660-677 e667. 10.1016/j.ccell.2023.03.007.
6. Behan, F.M., Iorio, F., Picco, G., Goncalves, E., Beaver, C.M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019). Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 568, 511-516. 10.1038/s41586-019-1103-9.
7. Ungricht, R., Guibbal, L., Lasbennes, M.C., Orsini, V., Beibel, M., Waldt, A., Cuttat, R., Carbone, W., Basler, A., Roma, G., et al. (2022). Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis. Cell Stem Cell 29, 160-175 e167. 10.1016/j.stem.2021.11.001.
8. Murakami, K., Terakado, Y., Saito, K., Jomen, Y., Takeda, H., Oshima, M., and Barker, N. (2021). A genome-scale CRISPR screen reveals factors regulating Wnt-dependent renewal of mouse gastric epithelial cells. Proc Natl Acad Sci U S A 118. 10.1073/pnas.2016806118.
9. Ringel, T., Frey, N., Ringnalda, F., Janjuha, S., Cherkaoui, S., Butz, S., Srivatsa, S., Pirkl, M., Russo, G., Villiger, L., et al. (2020). Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-beta Resistance. Cell Stem Cell 26, 431-440 e438. 10.1016/j.stem.2020.02.007.
10. Takeda, H., Kataoka, S., Nakayama, M., Ali, M.A.E., Oshima, H., Yamamoto, D., Park, J.W., Takegami, Y., An, T., Jenkins, N.A., et al. (2019). CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Proc Natl Acad Sci U S A 116, 15635-15644. 10.1073/pnas.1904714116.
11. Han, K., Pierce, S.E., Li, A., Spees, K., Anderson, G.R., Seoane, J.A., Lo, Y.H., Dubreuil, M., Olivas, M., Kamber, R.A., et al. (2020). CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. Nature 580, 136-141. 10.1038/s41586-020-2099-x.
12. Thomas, L.W., Esposito, C., Morgan, R.E., Price, S., Young, J., Williams, S.P., Maddalena, L.A., McDermott, U., and Ashcroft, M. (2021). Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia. Commun Biol 4, 615. 10.1038/s42003-021-02098-x.
13. Jain, I.H., Calvo, S.E., Markhard, A.L., Skinner, O.S., To, T.L., Ast, T., and Mootha, V.K. (2020). Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism. Cell 181, 716-727 e711. 10.1016/j.cell.2020.03.029.
14. Yang, J., Ledaki, I., Turley, H., Gatter, K.C., Montero, J.C., Li, J.L., and Harris, A.L. (2009). Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann N Y Acad Sci 1177, 185-197. 10.1111/j.1749-6632.2009.05027.x.
15. Gan, E.S., and Ooi, E.E. (2020). Oxygen: viral friend or foe? Virol J 17, 115. 10.1186/s12985-020-01374-2.
16. Thannickal, V.J. (2009). Oxygen in the evolution of complex life and the price we pay. Am J Respir Cell Mol Biol 40, 507-510. 10.1165/rcmb.2008-0360PS.
17. Lee, P., Chandel, N.S., and Simon, M.C. (2020). Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol 21, 268-283. 10.1038/s41580-020-0227-y.
18. Kaelin, W.G., Jr., and Ratcliffe, P.J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30, 393-402. 10.1016/j.molcel.2008.04.009.
19. Chakraborty, A.A., Laukka, T., Myllykoski, M., Ringel, A.E., Booker, M.A., Tolstorukov, M.Y., Meng, Y.J., Meier, S.R., Jennings, R.B., Creech, A.L., et al. (2019). Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science 363, 1217-1222. 10.1126/science.aaw1026.
20. Liang, Y., Ruan, W., Jiang, Y., Smalling, R., Yuan, X., and Eltzschig, H.K. (2023). Interplay of hypoxia-inducible factors and oxygen therapy in cardiovascular medicine. Nat Rev Cardiol. 10.1038/s41569-023-00886-y.
21. Singleton, D.C., Macann, A., and Wilson, W.R. (2021). Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol 18, 751-772. 10.1038/s41571-021-00539-4.
22. Pelullo, M., Zema, S., Nardozza, F., Checquolo, S., Screpanti, I., and Bellavia, D. (2019). Wnt, Notch, and TGF-beta Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer. Front Genet 10, 711. 10.3389/fgene.2019.00711.
23. Egeblad, M., Nakasone, E.S., and Werb, Z. (2010). Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18, 884-901. 10.1016/j.devcel.2010.05.012.
24. Harris, A.L. (2002). Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38-47. 10.1038/nrc704.
25. Gavish, A., Tyler, M., Greenwald, A.C., Hoefflin, R., Simkin, D., Tschernichovsky, R., Galili Darnell, N., Somech, E., Barbolin, C., Antman, T., et al. (2023). Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598-606. 10.1038/s41586-023-06130-4.
26. Fang, J., Singh, S., Cheng, C., Natarajan, S., Sheppard, H., Abu-Zaid, A., Durbin, A.D., Lee, H.W., Wu, Q., Steele, J., et al. (2023). Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. Nat Commun 14, 4003. 10.1038/s41467-023-39717-6.
27. Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W.K., Luna, A., La, K.C., Dimitriadoy, S., Liu, D.L., Kantheti, H.S., Saghafinia, S., et al. (2018). Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173, 321-337 e310. 10.1016/j.cell.2018.03.035.
28. Knijnenburg, T.A., Wang, L., Zimmermann, M.T., Chambwe, N., Gao, G.F., Cherniack, A.D., Fan, H., Shen, H., Way, G.P., Greene, C.S., et al. (2018). Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23, 239-254 e236. 10.1016/j.celrep.2018.03.076.
29. Biamonti, G., and Caceres, J.F. (2009). Cellular stress and RNA splicing. Trends Biochem Sci 34, 146-153. 10.1016/j.tibs.2008.11.004.
30. Liu, L., Wise, D.R., Diehl, J.A., and Simon, M.C. (2008). Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J Biol Chem 283, 31153-31162. 10.1074/jbc.M805056200.
31. Rios-Lopez, D.G., Tecalco-Cruz, A.C., Martinez-Pastor, D., Sosa-Garrocho, M., Tapia-Urzua, G., Aranda-Lopez, Y., Ortega-Dominguez, B., Recillas-Targa, F., Vazquez-Victorio, G., and Macias-Silva, M. (2023). TGF-beta/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells. Heliyon 9, e21519. 10.1016/j.heliyon.2023.e21519.
32. Li, W., Xu, H., Xiao, T., Cong, L., Love, M.I., Zhang, F., Irizarry, R.A., Liu, J.S., Brown, M., and Liu, X.S. (2014). MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol 15, 554. 10.1186/s13059-014-0554-4.
33. Bissell, D.M., Anderson, K.E., and Bonkovsky, H.L. (2017). Porphyria. N Engl J Med 377, 862-872. 10.1056/NEJMra1608634.
34. Fontanellas, A., and Avila, M.A. (2022). Hydroxymethylbilane synthase (aka porphobilinogen deaminase): A novel metabolic tumor suppressor gene in hepatocellular carcinoma. J Hepatol 77, 912-914. 10.1016/j.jhep.2022.06.023.
35. Molina, L., Zhu, J., Trepo, E., Bayard, Q., Amaddeo, G., Consortium, G., Blanc, J.F., Calderaro, J., Ma, X., Zucman-Rossi, J., and Letouze, E. (2022). Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. J Hepatol 77, 1038-1046. 10.1016/j.jhep.2022.05.018.
36. Korkut, A., Zaidi, S., Kanchi, R.S., Rao, S., Gough, N.R., Schultz, A., Li, X., Lorenzi, P.L., Berger, A.C., Robertson, G., et al. (2018). A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-beta Superfamily. Cell Syst 7, 422-437 e427. 10.1016/j.cels.2018.08.010.
37. Hernandez-Gerez, E., Dall'Angelo, S., Collinson, J.M., Fleming, I.N., and Parson, S.H. (2020). Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMA. Ann Clin Transl Neurol 7, 1580-1593. 10.1002/acn3.51134.
38. Orpinell, M., Fournier, M., Riss, A., Nagy, Z., Krebs, A.R., Frontini, M., and Tora, L. (2010). The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates. EMBO J 29, 2381-2394. 10.1038/emboj.2010.125.
39. Yap, T.A., Daver, N., Mahendra, M., Zhang, J., Kamiya-Matsuoka, C., Meric-Bernstam, F., Kantarjian, H.M., Ravandi, F., Collins, M.E., Francesco, M.E.D., et al. (2023). Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med 29, 115-126. 10.1038/s41591-022-02103-8.
40. Trigos, A.S., Pearson, R.B., Papenfuss, A.T., and Goode, D.L. (2018). How the evolution of multicellularity set the stage for cancer. Br J Cancer 118, 145-152. 10.1038/bjc.2017.398.
41. Trigos, A.S., Pearson, R.B., Papenfuss, A.T., and Goode, D.L. (2017). Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors. Proc Natl Acad Sci U S A 114, 6406-6411. 10.1073/pnas.1617743114.
42. Chen, H., Lin, F., Xing, K., and He, X. (2015). The reverse evolution from multicellularity to unicellularity during carcinogenesis. Nat Commun 6, 6367. 10.1038/ncomms7367.
43. Rao, R.C., and Dou, Y. (2015). Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15, 334-346. 10.1038/nrc3929.
44. Astolfi, A., Fiore, M., Melchionda, F., Indio, V., Bertuccio, S.N., and Pession, A. (2019). BCOR involvement in cancer. Epigenomics 11, 835-855. 10.2217/epi-2018-0195.
45. Raj, N., Wang, M., Seoane, J.A., Zhao, R.L., Kaiser, A.M., Moonie, N.A., Demeter, J., Boutelle, A.M., Kerr, C.H., Mulligan, A.S., et al. (2022). The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Mol Cell 82, 2370-2384 e2310. 10.1016/j.molcel.2022.04.010.
46. Wei, T., Li, J., Zhang, J., Zhang, Q., Liu, X., Chen, Q., Wen, L., Ma, K., Chen, W., Zhao, J., et al. (2023). Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation. Cell Rep 42, 112704. 10.1016/j.celrep.2023.112704.
47. Hou, Y., Zhang, X., Yao, H., Hou, L., Zhang, Q., Tao, E., Zhu, X., Jiang, S., Ren, Y., Hong, X., et al. (2023). METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. EMBO Rep 24, e56325. 10.15252/embr.202256325.
48. Yang, Z., Yang, S., Cui, Y.H., Wei, J., Shah, P., Park, G., Cui, X., He, C., and He, Y.Y. (2021). METTL14 facilitates global genome repair and suppresses skin tumorigenesis. Proc Natl Acad Sci U S A 118. 10.1073/pnas.2025948118.
49. Lombardi, O., Li, R., Halim, S., Choudhry, H., Ratcliffe, P.J., and Mole, D.R. (2022). Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature. Cell Rep 41, 111652. 10.1016/j.celrep.2022.111652.
50. Yoda, A., Adelmant, G., Tamburini, J., Chapuy, B., Shindoh, N., Yoda, Y., Weigert, O., Kopp, N., Wu, S.C., Kim, S.S., et al. (2015). Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance. Nat Med 21, 71-75. 10.1038/nm.3751.
51. Ackerman, D., and Simon, M.C. (2014). Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol 24, 472-478. 10.1016/j.tcb.2014.06.001.
52. Hall, Z., Wilson, C.H., Burkhart, D.L., Ashmore, T., Evan, G.I., and Griffin, J.L. (2020). Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancer. J Lipid Res 61, 1390-1399. 10.1194/jlr.RA120000899.
53. Shachaf, C.M., Perez, O.D., Youssef, S., Fan, A.C., Elchuri, S., Goldstein, M.J., Shirer, A.E., Sharpe, O., Chen, J., Mitchell, D.J., et al. (2007). Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Blood 110, 2674-2684. 10.1182/blood-2006-09-048033.
54. Koh, C.M., Bezzi, M., Low, D.H., Ang, W.X., Teo, S.X., Gay, F.P., Al-Haddawi, M., Tan, S.Y., Osato, M., Sabo, A., et al. (2015). MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature 523, 96-100. 10.1038/nature14351.
55. Kryukov, G.V., Wilson, F.H., Ruth, J.R., Paulk, J., Tsherniak, A., Marlow, S.E., Vazquez, F., Weir, B.A., Fitzgerald, M.E., Tanaka, M., et al. (2016). MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 351, 1214-1218. 10.1126/science.aad5214.
56. Appleby, T.C., Erion, M.D., and Ealick, S.E. (1999). The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase at 1.7 A resolution provides insights into substrate binding and catalysis. Structure 7, 629-641. 10.1016/s0969-2126(99)80084-7.
57. Li, W., Koster, J., Xu, H., Chen, C.H., Xiao, T., Liu, J.S., Brown, M., and Liu, X.S. (2015). Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol 16, 281. 10.1186/s13059-015-0843-6.
58. Li, H., and Durbin, R. (2010). Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595. 10.1093/bioinformatics/btp698.
59. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., and Genome Project Data Processing, S. (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079. 10.1093/bioinformatics/btp352.
60. Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., and Greenleaf, W.J. (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10, 1213-1218. 10.1038/nmeth.2688.
61. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., and Liu, X.S. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137. 10.1186/gb-2008-9-9-r137.
62. Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842. 10.1093/bioinformatics/btq033.
63. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., and Glass, C.K. (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576-589. 10.1016/j.molcel.2010.05.004.
64. Thorvaldsdottir, H., Robinson, J.T., and Mesirov, J.P. (2013). Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14, 178-192. 10.1093/bib/bbs017.